Home Service company 2022 Phase I CRO Benchmarking Report with Key Company Service Quality Profiles

2022 Phase I CRO Benchmarking Report with Key Company Service Quality Profiles


DUBLIN, May 11, 2022 /PRNewswire/ — The “Phase I CRO Benchmarking (14th Ed.)” report has been added to from ResearchAndMarkets.com offer.

The CRO Benchmarking report was designed with two objectives. The first is to help sponsors make more informed CRO selections. It can be difficult to find the right person for a particular sponsoring organization or trial. And without prior experience with a CRO, it is difficult to judge the performance of the CRO.

Main topics:

  • Service provider selection process
  • Perceptions and interactions of service providers
  • Performance and loyalty of service providers
  • Enterprise Service Quality Profiles

186 experienced Phase I outsourcers shared their insights into 547 recent encounters with service providers. The publisher analyzed a variety of factors around CRO selection and shared performance data from 32 CROs across 22 attributes across multiple categories (budget factors, delivery factors, staff characteristics, accessibility, and services).

The second objective of the report is to help CROs optimize their operational and marketing strategies. Knowing your customers’ ratings of your strengths and weaknesses can be invaluable in developing and marketing a successful offer. With this report, you will understand where your business performance shines and where you may need to close the gap against your competitors. This information can then be used to design marketing materials that effectively promote your company‘s strengths and differentiators.

Main topics covered:

Service provider selection process

  • Primary Section Takeaways
  • Preferred Supplier Agreements
  • Selection attributes
  • Use of external consultants for CRO
  • Identification and selection
  • Perceptions and interactions of service providers
  • Primary Section Takeaways
  • Leadership, Familiarity, and Reported Use of Phase I
  • Service Provider Preference
  • Service provider preference among users
  • Perception of costs
  • Cost experience among users
  • Summary

Performance and loyalty of service providers

  • Primary Section Takeaways
  • Budget factors
  • Delivery Factors
  • Staff characteristics
  • Accessibility
  • Services
  • A note on Harvey Ball’s calculations
  • Performance between service providers
  • CRO Performance: Budget Factors
  • CRO Performance: Delivery Factors
  • CRO performance: staff characteristics
  • CRO Performance: Accessibility
  • CRO Performance: Services
  • Customer loyalty: 2022
  • Customer loyalty: 3-year rolling average

Enterprise Service Quality Profiles

Study data

  • Phase I leaders, spontaneous
  • Other answers
  • Phase I Leaders, Guests
  • Knowledge of the service provider
  • Service Provider Knowledge – Additional Providers
  • Service Provider Reported Usage
  • Service Provider Preference
  • Service provider differentiation
  • Perceptions of service provider costs
  • Use of Preferred Providers
  • Number of preferred suppliers
  • Selection drivers: selection from
  • Preferred Suppliers
  • Preferred Supplier Attributes Are Gaining Importance
  • Selection drivers: when not in use
  • Preferred Suppliers
  • Selection factors: no preferred supplier
  • The attributes of the service provider are gaining in importance:
  • No preferred provider
  • Use of external consultants for the identification of CROs
  • and Selection
  • Detailed Service Provider Analytics
    • Altasciences (Algorithm, Vince, WCCT)
    • Services BioPharma Inc.
    • Bioassay
    • Catalyst of clinical research
    • Celerion
    • CDR
    • Covance/Labcorp
    • Clinical trials and CTI consulting
    • DCRI-Duke
    • Eurofins (including bioskin)
    • Facade
    • ICON (including PRA)
    • Innovaderm
    • Questions about this report
    • IQVIA
    • Lambda
    • Medpace
    • NAMSA (including Clinlogix)
    • Novotech
    • Novum
    • Nuvisan
    • Parexel
    • Pharm Olam International
    • PLR
    • Precision for medicine
    • PSR
    • clinical quotient
    • SGS Life Sciences
    • Syro Clinpharm
    • Spaulding Clinic
    • Syneos Health (including Synteract)
    • TKL Search
  • Global clinical trials


  • type of company
  • Office location
  • Job title
  • Decisional responsibility
  • Outsourcing implication by phase
  • Involvement in clinical development
  • Therapeutic areas of responsibility
  • Years of industry experience

For more information about this report visit https://www.researchandmarkets.com/r/msksg8

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets